WELLMIND VERTIGO- semecarpus anacardium juice, anamirta cocculus seed, conium maculatum flowering top, kerosene, and selenium ta

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

SEMECARPUS ANACARDIUM JUICE (UNII: Y0F0BU8RDU) (SEMECARPUS ANACARDIUM JUICE - UNII:Y0F0BU8RDU), ANAMIRTA COCCULUS SEED (UNII: 810258W28U) (ANAMIRTA COCCULUS SEED - UNII:810258W28U), CONIUM MACULATUM FLOWERING TOP (UNII: Q28R5GF371) (CONIUM MACULATUM FLOWERING TOP - UNII:Q28R5GF371), PETROLEUM ALKYLATE (UNII: Y61895R84U) (PETROLEUM ALKYLATE - UNII:Y61895R84U), SELENIUM (UNII: H6241UJ22B) (SELENIUM - UNII:H6241UJ22B)

Disponible depuis:

MediNatura Inc.

DCI (Dénomination commune internationale):

SEMECARPUS ANACARDIUM JUICE

Composition:

SEMECARPUS ANACARDIUM JUICE 6 [hp_X]

Mode d'administration:

ORAL

Type d'ordonnance:

PRESCRIPTION DRUG

indications thérapeutiques:

WellMindTM Vertigo Tablets are a homeopathic drug product indicated for the treatment of vertigo/dizziness ofvarious origins; mild cognitive impairment (MCI) such as lack of concentration and forgetfulness. • WellMindTM Vertigo Tablets are contraindicated in patients with known hypersensitivity to WellMindTM Vertigo or any of its ingredients. • Do not use during pregnancy or breastfeeding.

Statut de autorisation:

unapproved homeopathic

Résumé des caractéristiques du produit

WELLMIND VERTIGO- SEMECARPUS ANACARDIUM JUICE, ANAMIRTA COCCULUS SEED,
CONIUM MACULATUM FLOWERING TOP, KEROSENE, AND SELENIUM TABLET
MEDINATURA INC.
_Disclaimer: This homeopathic product has not been evaluated by the
Food and Drug_
_Administration for safety or efficacy. FDA is not aware of scientific
evidence to support_
_homeopathy as effective._
----------
WELLMIND VERTIGO RX TABLET
DESCRIPTION
EACH 300 MG TABLET CONTAINS:
Active Ingredients:
Ingredient name Potency Quantity Final dilution
Anacardium orientale 6X 10 mg 7.5X
Cocculus indicus 4X 210 mg 4.15X
Conium maculatum 3X 30 mg 4X
Petroleum 8X 20 mg 9.2X
Selenium metallicum 6X 10 mg 7.5X
Selenium metallicum 12X 10 mg 13.5X
Selenium metallicum 30X 10 mg 31.5X
INDICATIONS & USAGE
WellMind
Vertigo Tablets are a homeopathic drug product indicated for the
treatment
of vertigo/dizziness ofvarious origins; mild cognitive impairment
(MCI) such as lack of
concentration and forgetfulness.
DOSAGE AND ADMINISTRATION
GENERAL CONSIDERATIONS
• The dosage schedules listed below can be used as a general guide
for the
administration of WellMind
Vertigo Tablets.
• Allow tablets to dissolve completely in the mouth, do not swallow.
STANDARD DOSAGE: ADULTS AND CHILDREN 12 YEARS AND OLDER:
3 tablets per day, taking 1 tablet every 4 to 6 hours.
ACUTE DOSAGE:ADULTS AND CHILDREN 12 YEARS AND OLDER:
1 tablet every ½ to 1 hour until symptoms lessen, then continue with
standard dosage.
DO NOT exceed 12 tablets in 24 hours.
TM
TM
CONTRAINDICATIONS
• WellMind
Vertigo Tablets are contraindicated in patients with known
hypersensitivity
to WellMind
Vertigo or any of its ingredients.
• DO NOT use during pregnancy or breastfeeding.
WARNINGS
None
ADVERSE REACTIONS
Post-marketing Experience
• No adverse events with a causal relationship to WellMind
Vertigo tablets have been
reported.
OVERDOSAGE
No negative effects of an overdose have been reported and none are
expected due to
the homeopathic dilutions.
CLINICAL PHARMACOLOGY
MECHANISM OF ACTION
The exact mechanism of WellMind
Vertigo